Clinical trials: Histologically or Cytologically Documented Solid Tumors
Histologically or Cytologically Documented Solid Tumors
A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors
This study is an open-label, dose-finding study to determine the target or maximum-tolerated dose and to characterize the safety and pharmacokinetic profile of AMG 706 administered in combination with erlotinib with or without…
- Trial name
- NCT01235416
- Testing
- AMG 706
- Volunteers
- 57 people
- Sponsor
- Amgen